A 62-year-old woman on metformin (2 g/day) for type 2 diabetes is prescribed trimethoprim-sulfamethoxazole (TMP-SMX) for a urinary tract infection. After 3 days, she develops nausea, fatigue, and a serum creatinine rise from 0.9 to 1.4 mg/dL. Which investigation is most appropriate to identify the mechanism of renal dysfunction in this drug interaction?

Explanation

## Clinical Context: TMP-SMX–Metformin Interaction **Key Point:** TMP-SMX (especially trimethoprim) inhibits renal tubular secretion of creatinine and metformin, reducing their clearance. Additionally, TMP-SMX can cause acute tubular necrosis (ATN). The combination leads to metformin accumulation and lactic acidosis risk. ## Why Serum Lactate and ABG? **High-Yield:** The primary concern in this interaction is **metformin-associated lactic acidosis (MALA)**, which is life-threatening. Serum lactate directly measures lactate levels, and ABG reveals the metabolic acidosis (low pH, low HCO₃⁻) that characterizes MALA. ### Pathophysiology 1. **Trimethoprim blocks renal secretion** of both creatinine and metformin. 2. **Metformin accumulates** in the blood and tissues. 3. **Metformin impairs hepatic lactate clearance** and shifts metabolism toward lactate production. 4. **Lactic acidosis develops** → nausea, fatigue, dyspnoea, altered mental status. ### Investigation Rationale | Investigation | Utility in TMP-SMX–Metformin Interaction | |---|---| | **Serum lactate** | Gold standard for detecting MALA; lactate > 5 mmol/L is diagnostic | | **ABG (pH, HCO₃⁻)** | Confirms metabolic acidosis; pH < 7.35 and HCO₃⁻ < 15 mEq/L support MALA | | **Urine anion gap** | Assesses renal tubular acidosis; not relevant in MALA | | **Urine microscopy** | Detects ATN (muddy brown casts) but is nonspecific and does not guide acute management | | **Serum electrolytes** | May show hyperkalaemia (from renal failure) but not diagnostic of MALA | **Clinical Pearl:** MALA is a medical emergency. The combination of elevated creatinine, nausea, and fatigue in a patient on metformin + TMP-SMX should trigger immediate lactate and ABG measurement. If lactate > 5 mmol/L and pH < 7.35, **stop metformin immediately**, discontinue TMP-SMX, and initiate haemodialysis (which removes both lactate and metformin). **Mnemonic:** MALA = **M**etformin **A**ccumulation → **L**actic **A**cidosis. The triad is: elevated lactate, metabolic acidosis (low pH, low HCO₃⁻), and renal dysfunction. ## Management 1. **Stop metformin and TMP-SMX immediately.** 2. **Check serum lactate and ABG** (this question's answer). 3. **If MALA confirmed:** haemodialysis, supportive care, treat underlying infection with alternative antibiotic (e.g., nitrofurantoin, cephalexin). **Warning:** Do not delay lactate/ABG measurement to perform urine studies — MALA is time-sensitive.